About Us
CytoImage was established in 2020 by Associate Professor Tania Vu and Dr. Thomas Jacob from OHSU Knight Cancer Institute and the Dept. of Biomedical Engineering . We are a seed stage company expediting the commercialization of a patented single cell functional precision medicine platform. Our goal is to empower the expanding universe of cancer targets and accelerate the clinical development of the most promising combination therapies to extend survival and escape disease relapse.
Our Team
Meet the Team

Dan Snyder, MBA
CEO, Commercial Development

Tania Vu, PhD
CSO, Co-founder

Sandra Shotwell, PhD
COO

Thomas Jacob, PhD
VP of R&D, Co-founder

Ann Bunnenberg, PhD, JD
Board Chair, Co-founder

Shula Jaron, PhD
Director
People we trust
Partnerships and Collaborations




Investors





Partner with Us.
The CytoImage leadership team is actively looking for investment and commercial partners to accelerate the development of single cell functional precision medicine.